Arena Pharmaceuticals Completes Trial Comparing OnceDaily Extended Release Formulation of Ralinepag with TwiceDaily Immediate Release Formulation in Normal Healthy Volunteers

SAN DIEGO June 29 2017 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced the completion of a Phase 1 comparative bioavailability study evaluating the pharmacokinetic PK profile of extended release XR ralinepag compared to the immediate rel...